Herborium Group, Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Agnes Olszewski
- Full Time Employees
- 2
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 14090 Southwest Freeway Sugar Land TX United States of America 07024
- IPO Date
- Jul 13, 1998
- Website
- herborium.com
- Similar Companies
- Business
- Herborium Group, Inc. Herborium Group, Inc. (HBRM) operates as a botanical therapeutics company that develops, licenses, and markets proprietary botanical-based medicinal products targeting unmet medical needs in disease treatment, management, and prevention; its core offerings include AcnEase, a clinically validated all-botanical systemic treatment for teen and adult acne as well as rosacea symptoms, alongside the Lasting Energy, Lasting Pleasure, and MaleForce series (encompassing MaleForce LL and MaleForce RR) for energy, women's health, men's health, and sexual wellness concerns derived from Traditional Chinese Medicine formulations. The company also provides the Virtual Institute for Natural and Complementary Medicine (VINCM), an integrative educational platform for healthcare professionals and consumers, and explores additional pipeline candidates in areas such as prostate health (BPH), liver diseases, women's health, sexual disorders, arthritis, and antibiotic-resistant infections. Founded in 1996 and headquartered in Teaneck, New Jersey, Herborium Group, Inc. sells its products primarily in the United States, United Kingdom, and continental Europe through distributors, specialty retailers, and e-commerce channels, serving consumers and healthcare professionals seeking natural alternatives between pharmaceuticals and nutraceuticals. Recent developments include an expanded partnership with the HUT Group in 2014 targeting £500,000 in European sales for AcnEase and related products, while the company maintains a proactive regulatory strategy under FDA botanical drug guidance and continues to leverage management's expertise in U.S., European, and PRC markets without reported acquisitions, funding rounds, or major operational shifts in the last 1-2 years.
Herborium® Moves Into Manufacturing Phase For Its New Protein Bars;
Herborium Group progresses with Distribution Agreements for AcnEase® and its Cosmeceuticals to take advantage of $8Billion French Cosmetic Market;
Herborium® Targets $6.5 Billion French Amazon Market for its unique AcnEase® Botanical Therapeutic® and its New Skin Protein Bar
Herborium® Targets Distribution of its New Skin Protein Bar by Whole Foods, TraderJoe, Walmart and Target the Fall 2021
Herborium Sales for First Quarter 2021 rises 20% Debt decreased $500.000
Herborium Moves to the Next Level in Building a Disruptive, Integrated, Natural Medicine Content and Commerce Platform
Herborium® Group Inc. Skin Health Products to Enter $250 Million Pacific Asian Market
Herborium Group Introduces Proprietary Two- in- One Biodegradable, Multi-Use Facial Mask
Herborium® Group Inc, Shareholders Update Letter